SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : bluebird bio Inc. -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (8)11/27/2013 8:25:48 AM
From: Biotech Jim  Respond to of 163
 
That is an amazing video of Emma, Carl June and colleagues. That is not the one that I was referring to , but it sums up the story. the one I watched was around 40 minutes, went into many details, and spoke of the engineering challenges inherent in the methodology to roll it out big time.

Thanks for the link!



To: rkrw who wrote (8)12/8/2013 9:35:02 PM
From: Biotech Jim1 Recommendation

Recommended By
rkrw

  Respond to of 163
 
I found the link to the Carl June lecture that I had mentioned. It is a bit long, about 55 min, but worth every minute. The Cancer Research Institute sponsored this talk, and is titled: "Engineering T Cells to Conquer Cancer". This goes into some detail on the background, a vignette on Emma, some views on next steps, and a Q and A. This is from June 14, 2013.

youtube.com


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News